ACTELION'S BOARD OF DIRECTORS: OUR BEST PRACTICES ...
ACTELION'S BOARD OF DIRECTORS: OUR BEST PRACTICES ...
ACTELION'S BOARD OF DIRECTORS: OUR BEST PRACTICES ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ARMIN KESSLER<br />
27<br />
© 2011 Actelion Pharmaceuticals Ltd<br />
� Armin Kessler received a degree in Physics and Chemistry from Pretoria University<br />
in South Africa, a degree in Chemical Engineering from the University of Cape Town,<br />
South Africa, a Juris Doctorate from Seton Hall University, New Jersey, and Dr. h.c.<br />
in Business Administration from the University of Pretoria<br />
� Armin served as Chief Operating Officer of F. Hoffmann-La Roche Ltd in Basel<br />
Switzerland from 1990 to 1995. Prior to being appointed COO, he held several senior<br />
positions at Roche, including head of the pharmaceutical and diagnostic divisions.<br />
Earlier positions in his career include Director of Pharmaceutical Marketing<br />
Worldwide for Sandoz (now Novartis), and President of Sandoz KK in Tokyo<br />
� From 1992 to 1995, Armin was President of the European Federation of<br />
Pharmaceutical Industry Associations (EFPIA)<br />
� He currently serves on the board of The Medicines Company and Gen-Probe, and<br />
has served on the boards of F. Hoffmann-La Roche, Syntex and Genentech<br />
08 March 2011 White Paper